Panasonic introduces smart glasses for the visually impaired

MADRID, Jan. 10 (Portaltic/EP) –

Panasonic has presented smart glasses for people with audiovisual disabilities with which it promises to offer the support they need to improve their mobility and autonomy.

To create this device, the technological manufacturer has joined forces with Biel Glassesa Barcelona-based startup that develops technology that combines both artificial intelligence (AI) and mixed reality (MR) and robotics.

In that way, this solution combines reality glasses Panasonic’s virtual 5.2K HDR with Biel Glasses’ low vision technology, which uses AI and robotics to interpret the scene, and MRI to adapt the vision available to the wearer.

The two companies believe that, thanks to this innovation, “mobility problems are solved caused by low vision, which are aggravated when there is loss of peripheral vision”, as they have advanced in a statement.

In this way, these smart glasses allow users to perceive obstacles and other risks and dangers so that they can move safely and independently.

For this to be possible, AI and robotics are in charge of analyzing the circumstances surrounding the user and analyzing, in real time, the elements that cameras and sensors capture.

In this first phase, possible dangers that arise for mobility are detected, such as obstacles, steps or holes. MRI is then used to warn the user so that he can perceive them by means of graphic signals adapted to the remaining vision of the user.

To carry out this adaptation, optometrists adjust the functions of smart glasses according to the specific conditions and needs of each person. In this way, the degree of vision is improved through optimal image processing, with an adjustment of the zoom, lighting and contrast, among other features.

From Panasonic they emphasize that the technology that integrates this device has achieved a compact size, light weight and low power consumption by adopting uOLED display panels and ‘pancake’ lenses.

Both companies that develop this solution, which has been tested within the framework of CES 2023, have indicated that will continue to promote technological development and clinical verification to continue launching this type of solution.